Royal Harbor Partners, LLC Bristol Myers Squibb CO Transaction History

Royal Harbor Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$53.63 - $62.52 $1.05 Million - $1.23 Million	-19,636 Closed	0 $0
Q3 2021 Oct 19, 2021	BUY	$59.17 - $69.31 $10,177 - $11,921	172 Added 0.88%	19,636 $1.16 Million
Q2 2021 Jul 16, 2021	BUY	$61.91 - $67.42 $35,969 - $39,171	581 Added 3.08%	19,464 $1.3 Million
Q1 2021 Apr 12, 2021	BUY	$59.34 - $66.74 $63,612 - $71,545	1,072 Added 6.02%	18,883 $1.19 Million
Q4 2020 Jan 25, 2021	BUY	$57.74 - $65.43 $216,582 - $245,427	3,751 Added 26.68%	17,811 $1.11 Million
Q3 2020 Oct 08, 2020	BUY	$57.43 - $63.64 $3,273 - $3,627	57 Added 0.41%	14,060 $848,000
Q2 2020 Aug 10, 2020	SELL	$54.82 - $64.09 $339,719 - $397,165	-6,197 Reduced 30.68%	14,003 $823,000
Q1 2020 Apr 10, 2020	BUY	$46.4 - $67.43 $937,280 - $1.36 Million	20,200 New	20,200 $1.13 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $122B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Royal Harbor Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Royal Harbor Partners, LLC with notifications on news.